KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to New Jersey

S3897 • 2026

Requires performance of myeloma screening under certain circumstances.

Requires performance of myeloma screening under certain circumstances.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
McKnight, Angela V.
Last action
2026-03-12
Official status
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Requires performance of myeloma screening under certain circumstances.

Requires performance of myeloma screening under certain circumstances.

What This Bill Does

  • Requires performance of myeloma screening under certain circumstances.
  • Topic: Health, Human Services and Senior Citizens Fiscal note: This bill has not been certified by OLS for a fiscal note.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-03-12 New Jersey Legislature

    Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Official Summary Text

Requires performance of myeloma screening under certain circumstances.
Topic:
Health, Human Services and Senior Citizens
Fiscal note:
This bill has not been certified by OLS for a fiscal note.

Current Bill Text

Read the full stored bill text 
S3897

SENATE, No. 3897

STATE OF NEW JERSEY

222nd LEGISLATURE

�

INTRODUCED MARCH 12, 2026

Sponsored by:

Senator� ANGELA V. MCKNIGHT

District 31 (Hudson)

SYNOPSIS

���� Requires performance of myeloma screening under
certain circumstances.

CURRENT VERSION OF TEXT

���� As introduced.

��

An Act
concerning myeloma screenings and supplementing Title
26 of the Revised Statutes.

����
Be It
Enacted
by the Senate and General Assembly of
the State of New Jersey:

���� 1.��� The Legislature finds
and declares that the American Cancer Society estimates that there will be
34,470 new cases of myeloma in 2022 in the United States.

���� The Legislature further finds
and declares that it is estimated that there will be 12,640 deaths in 2022 due
to myeloma according to the American Cancer Society.

���� The Legislature further finds
and declares that, in New Jersey, it is estimated that there will be 1,060
myeloma cases and 330 deaths in 2022.

���� The Legislature further finds
and declares that men have a higher myeloma incidence and death rate compared
to women, and African American men have the highest myeloma incidence and death
rate according to the American Society.

���� The Legislature therefore
determines that it is in the public interest to enact legislation requiring licensed
health care professionals who perform annual physical examinations on male
patients to include as part of those examinations a screening for myeloma.

���� 2.��� A licensed health care
professional who performs an annual physical examination on a male patient shall
include as part of that examination a screening for myeloma.

���� 3.��� This act shall take
effect immediately.

STATEMENT

���� This bill requires the
performance of a myeloma screening under certain circumstances.

���� Under the bill, a licensed
health care professional who performs an annual physical examination on a male
patient is to include as part of that examination a screening for myeloma.

���� Myeloma, also called multiple
myeloma, is a cancer of the plasma cells. �Plasma cells are white blood cells
that make antibodies which protect from infection.� In a case of myeloma,
cancerous plasma cells accumulate in the bone marrow and overcome healthy blood
cells. Rather than produce helpful antibodies, the cancer cells produce
abnormal proteins that can cause complications.

���� There are legislative findings
and declarations in the bill, which include that African-American men have the
highest myeloma incidence and death rates according to the American Cancer
Society.